Yoshii H
Nichidai Koko Kagaku. 1989 Sep;15(3):216-38.
Changes in body temperature and blood circulation wave been monitored to investigate the effect of some vasoconstrictor contained in a local anesthetic on living body. The results obtained are described below. Subjects selected were six healthy male students (23-29 years in age). Drugs used for the experiment were 3% tolycaine for local anesthetic added with 72 micrograms, 108 micrograms or 144 micrograms of epinephrine in epinephrine group; with 90 micrograms, 135 micrograms or 180 micrograms of norepinephrine in norepinephrine group, and with each 36 micrograms, 54 micrograms, 72 micrograms of epinephrine and 36 micrograms, 54 micrograms or 72 micrograms of norepinephrine in epinephrien + norepinephrine group. 1. Change in body temperature 1) Tympanic membrane temperature There was no significant difference between pre- and post injection values in all dose groups. 2) Average skin temperature in big toe The temperature was decreased significantly at 0-25 min. in epinephrine group, in norepinephrine group and in epinephrine + norepinephrine group, compared to that prior to injection. 2. Change in circulatory kinetics 1) Epinephrine group Heart rate and RPP was increased significantly at 0-40 min. (72 micrograms) and at 0-50 min. (108 micrograms and 144 micrograms) in epinephrine group. 2) Norepinephrine group In norepinephrine 90 micrograms group, blood pressure showed a significantly high level at 5-25 min. in systolic pressure and at 0-25 min. in diastolic pressure, compared to those prior to injection. In norepinephrine 135 micrograms group, blood pressure showed a significantly high level at 0-25 min. in systolic pressure and at 0-30 min. in diastolic pressure, compared to those prior to injection. In norepinephrine 180 micrograms group, blood pressure showed a significantly high level at 0-30 min. in systolic pressure and at 0-20 min. in diastolic pressure, compared to those prior to injection. MAP was significantly high level in mean artereial pressure of norepinephrine group at 0-20 min. compared to that prior to injection. Heart rate was increased significantly at 5-30 min. in norepinephrine 90 micrograms group, decreased significantly at 0-30 min. in norepinephrine 135 micrograms group, and decreased significantly at 0-20 min. in norepinephrine 180 micrograms group, compared to those prior to infection. RPP showed a low level at 5-20 min. in norepinephrine 90 micrograms group, at 10-15 min. in norepinephrine 135 micrograms group, and at 10 min. in norepinephrine 180 micrograms group, both being of significance when compared to those prior to injection.(ABSTRACT TRUNCATED AT 400 WORDS)
监测体温和血液循环的变化,以研究局部麻醉剂中所含某些血管收缩剂对活体的影响。所得结果如下所述。选取的受试者为6名健康男学生(年龄在23 - 29岁之间)。实验所用药物为:肾上腺素组中,3%的托利卡因局部麻醉剂添加72微克、108微克或144微克肾上腺素;去甲肾上腺素组中,添加90微克、135微克或180微克去甲肾上腺素;肾上腺素 + 去甲肾上腺素组中,分别添加36微克、54微克、72微克肾上腺素和36微克、54微克或72微克去甲肾上腺素。1. 体温变化 1)鼓膜温度 所有剂量组注射前后的值均无显著差异。2)大脚趾平均皮肤温度 在肾上腺素组、去甲肾上腺素组和肾上腺素 + 去甲肾上腺素组中,0 - 25分钟时温度较注射前显著降低。2. 循环动力学变化 1)肾上腺素组 在肾上腺素组中,0 - 40分钟(72微克)、0 - 50分钟(108微克和144微克)时心率和RPP显著升高。2)去甲肾上腺素组 在去甲肾上腺素90微克组中,收缩压在5 - 25分钟、舒张压在0 - 25分钟时较注射前显著升高。在去甲肾上腺素135微克组中,收缩压在0 - 25分钟、舒张压在0 - 30分钟时较注射前显著升高。在去甲肾上腺素180微克组中,收缩压在0 - 30分钟、舒张压在0 - 20分钟时较注射前显著升高。去甲肾上腺素组平均动脉压MAP在0 - 20分钟时较注射前显著升高。去甲肾上腺素90微克组心率在5 - 30分钟时显著升高,去甲肾上腺素135微克组在0 - 30分钟时显著降低,去甲肾上腺素180微克组在0 - 20分钟时显著降低,与感染前相比均有显著差异。去甲肾上腺素90微克组RPP在5 - 20分钟时、去甲肾上腺素135微克组在10 - 15分钟时、去甲肾上腺素180微克组在10分钟时均处于较低水平,与注射前相比均有显著差异。(摘要截断于400字)